Is Transformed Bone Marrow Cell Line a Substitute for Normal Bone Marrow Cells in Laser Photoradiation Therapy for Bone Marrow Purging?

References

• Livingston RB, Carter SK: Single Agents in Cancer Chemotherapy. New York, OT/Plenum, 1970, pp 16–165.
   Google Scholar
• Armitage JO, Gingrich RD, Klassen LW, et al: Trial of high-dose cytarabine, cyclophosphamide, total-body irradiation, and autologous marrow transplantation for refractory lymphoma. Cancer Treat Rep 70: 871–875, 1986.
   PubMedGoogle Scholar
• Phillips GL, Herzig RH, Lazarus HM, et al: Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous marrow. N Engl J Med 310: 1557–1561, 1984.
   PubMed Web of Science ®Google Scholar
• Waggoner, AS: Dye indicators of membrane potential. Ann Rev Biophys Bioeng 8: 47–67, 1979.
   PubMedGoogle Scholar
• Sieber F, Stuart RK, Rowely SD, et al: Dye mediated photolysis of normal and neoplastic hematopoietic cells. Leuk Res 11 (1): 43–49, 1987.
   Web of Science ®Google Scholar
• Pervaiz S, Gulliya K, Matthews JL, et al: Photosensitization of Burkitt lymphoma (Daudi) cells and normal bone marrow cells. (Abstr) Proc Soc Exp Biol Med (SW) 9, 1987.
   Google Scholar
• Valinsky JE, Easton TG, Reich E: Merocyanine 540 as a fluorescent probe of membranes: selective staining of leukemic and immature hemopoietic cells. Cell 13: 487–499, 1978.
   PubMed Web of Science ®Google Scholar
• Gulliya KS, Matthews JL: Photosensitization of leukemic cells and normal bone marrow cells by 514 nm laser light and effects of laser light on migration inhibition and lymphokine response. Cell Biol Intern Rep 12: 305–308, 1988.
   Google Scholar
• Gulliya KS, Pervaiz S, Nealon DG, et al: Laser light induced photosensitization of lymphoma cells and normal bone marrow cells in laser surgery: characterization and therapeutics. Proc Int Soc Opt Eng 907: 34–36, 1988.
   Google Scholar
• Gulliya K, Matthews JL, Fay J, et al: Eradication of human small cell lung carcinoma cells by photodynamic therapy: implications for autologous bone marrow purging. (Abstr) FASEB 2 (4): 1852, 1988.
   Google Scholar
• Gulliya KS, Matthews JL, Fay JW, et al: Increased survival of normal cells during laser photodynamic therapy: implications for ex vivo autologous bone marrow purging. Life Sci 42: 2651–2656, 1988.
   Web of Science ®Google Scholar
• Gulliya KS, Fay J, Dowben RM, et al: Elimination of leukemic cells by laser photodynamic therapy. Cancer Chemother Pharmacol, [in press 1988].
   Google Scholar
• Gulliya KS, Matthews JL, Dowben RM, et al: Eradication of myeloma therapy: implications for bone marrow purging. In AAAS Annual Meeting Abstracts, February 11–15, 1988, Boston, MA. Washington, DC, American Association for the Advancement of Science, (Abstr 209) 1988, p 101.
   Google Scholar
• Lanotte M, Scott D, Dexter TM, et al: Clonal preadipocyte cell lines with different phenotypes derived from murine marrow stroma: factors influencing growth and adipogenesis in vitro. J Cell Physiol 111: 177–186, 1982.
   PubMed Web of Science ®Google Scholar
• Zipori D, Toledo J, von der Mark K: Phenotypic heterogeneity among stromal cell lines from mouse bone marrow disclosed in their extracellular matrix composition and interactions with normal and leukemic cells. Blood 66: 447–455, 1985.
   PubMed Web of Science ®Google Scholar
• Song ZX, Shadduck RK, Innes DJ, et al: Hematopoietic factor production by a cell line (TC-1) derived from adherent murine marrow cells. Blood 66: 273–281, 1985.
   Web of Science ®Google Scholar
• Singer JW, Charbord P, Keating A, et al: Simian virus 40-transformed adherent cells from human long-term marrow cultures: cloned cell lines produce cells with stromal and hematopoietic characteristics. Blood 70: 464–474, 1987.
   PubMed Web of Science ®Google Scholar
• Bruce WR, Meeker BE, Valeriote FAJ: Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo. J Natl Cancer Inst 37: 233–245, 1966.
   PubMedGoogle Scholar
• Frei E III, Canellos GP: Dose: a critical factor in cancer chemotherapy. Am J Med 69: 585–594, 1980.
   PubMed Web of Science ®Google Scholar
• Gale RP: Autologous bone marrow transplantation in patients with cancer. J Am Med Assoc 243: 540–542, 1980.
   Web of Science ®Google Scholar
• Champlin RE, Gale RP: Role of bone marrow transplantation in the treatment of hematologic malignancies and solid tumors: critical review of syngeneic, autologous, and allogeneic transplants. Cancer Treat Rep 68: 145–161, 1984.
   Google Scholar
• Winston DJ, Gale RP, Meyer DV, et al: Infectious complications of human bone marrow transplantation. Med 58: 1–31, 1979.
   PubMed Web of Science ®Google Scholar
• Zander AR, Dicke KA, Vellekoop L, et al: Autografting in acute leukemia. In Gale RP, ed: Recent Advances in Bone Marrow Transplantation. New York, Alan R. Liss, Inc., 1983, p 659.
   Google Scholar
• Skipper HE, Schabel FM, Jr.: Quantitative and cytokinetic studies in experimental tumor systems. In Holland JF, Frei E, III, eds: Cancer Medicine, 2nd ed. Philadelphia, Lea and Febiger, [in press 1988].
   Google Scholar
• McKelvey EM, Gottlieb JA, Wilson HE, et al: Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma. Cancer 38: 1484–1493, 1976.
   PubMed Web of Science ®Google Scholar
• Schein PS, DeVita VT, Hubbard S, et al: Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma. Ann Intern Med 85: 417–422, 1976.
   PubMed Web of Science ®Google Scholar
• Ramsay N, LeBien T, Nesbit M, et al: Autologous bone marrow transplantation for patients with acute lymphoblastic leukemia in second or subsequent remission: results of bone marrow treated with monoclonal antibodies BA-1, BA-2, and BA-3 plus complement. Blood 66: 508–513, 1985.
   PubMed Web of Science ®Google Scholar
• Muirhead M, Martin PJ, Torok-Storb B, et al: Use of an antibody-ricin A-chain conjugate to delete neoplastic B cells from human bone marrow. Blood 62: 327–332, 1983.
   PubMed Web of Science ®Google Scholar
• Sieber F, Sieber-Blum M: Dye-mediated photosensitization of murine neuroblastoma cells. Cancer Res 46: 2072–2076, 1986.
   PubMed Web of Science ®Google Scholar
• Ciobanu N, Paietta E, et al: Etoposide as an in vitro purging agent for the treatment of acute leukemias and lymphomas in conjunction with autologous bone marrow transplantation. Exp Hematol 14: 626–635, 1986.
   PubMed Web of Science ®Google Scholar
• Kaizer H, Stuart RK, Brookmeyer R, et al: Autologous bone marrow transplantation in acute leukemia: A phase I study of in vitro treatment of marrow with 4-hydroperoxycyclophosphamide to purge tumor cells. Blood 65: 1504–1510, 1985.
   PubMed Web of Science ®Google Scholar
• Sieber F, Rao S, Rowley SD, et al: Dye-mediated photolysis of human neuroblastoma cells: implications for autologous bone marrow transplantation. Blood 68: 32–36, 1986.
   PubMed Web of Science ®Google Scholar
• Meagher RC, Sieber F, Spivak JL: Susceptibility to merocyanine 540-mediated photosensitization: A differential marker on murine hematopoietic progenitor cells. J Cell Physiol 116: 118–124, 1983.
   PubMed Web of Science ®Google Scholar